中华老年医学杂志2024,Vol.43Issue(10) :1345-1350.DOI:10.3760/cma.j.issn.0254-9026.2024.10.018

老年人炎症性肠病发病机制的研究进展与干细胞治疗

Research progress on pathogenesis of inflammatory bowel disease and stem cell therapy in the elderly

潘彤 罗晓英 白阳秋 江小柯 张炳勇
中华老年医学杂志2024,Vol.43Issue(10) :1345-1350.DOI:10.3760/cma.j.issn.0254-9026.2024.10.018

老年人炎症性肠病发病机制的研究进展与干细胞治疗

Research progress on pathogenesis of inflammatory bowel disease and stem cell therapy in the elderly

潘彤 1罗晓英 1白阳秋 1江小柯 1张炳勇1
扫码查看

作者信息

  • 1. 郑州大学人民医院消化内科,郑州 450000
  • 折叠

摘要

随着中国步入老龄化时代,老年人炎症性肠病(IBD)的患病率较前升高,衰老与炎症的联系似乎在老年IBD患者中更加显著.然而,目前的研究大多侧重于对其临床特点的描述,针对发病机制的探讨较少.本文总结了老年人IBD与青年人IBD的临床特征和治疗差异,深入探讨了衰老对老年人IBD发病可能的影响和干细胞移植疗法在老年人IBD治疗中的可能性,旨在为老年人IBD的临床研究提供新的思路.

Abstract

As China enters the aging era,the incidence rate and prevalence of inflammatory bowel disease(IBD)in the elderly have increased.The relationship between aging and inflammation appears to be more significant in elderly individuals with IBD.However,most current studies focus on describing the clinical characteristics of the disease,with limited research on its pathogenesis and treatment.In this review,we summarize the differences in clinical characteristics and treatment between elderly individuals with IBD and young individuals.We also discuss the impact of aging on elderly IBD and explore the possibility of stem cell transplantation therapy as a new approach for clinical management.Our aim is to provide fresh insights for the treatment of elderly IBD.

关键词

Crohn病/结肠炎,溃疡性/干细胞移植/免疫衰老

Key words

Crohn disease/Colitis,ulcerative/Stem cell transplantation/Immune senescence

引用本文复制引用

基金项目

河南省卫计委医学科技公关省部共建项目(SBGJ202001002)

出版年

2024
中华老年医学杂志
中华医学会

中华老年医学杂志

CSTPCD北大核心
影响因子:1.606
ISSN:0254-9026
段落导航相关论文